Thyroid eye disease is one of the most difficult diseases to predict, so it is often managed with collaboration between an endocrinologist and an ophthalmologist at Cleveland Clinic.
Patient on Newly FDA-Approved Teprotumumab Sees Dramatic Improvement in Thyroid Eye Disease
A new drug for thyroid eye disease, teprotumumab, also may be effective at treating vision loss due to disease-associated optic neuropathy.
Strabismus Surgery in Thyroid Eye Disease
A new technique developed by Cole Eye Institute’s Elias Traboulsi, MD, has been shown to improve surgical outcomes for the roughly 5 percent of patients with thyroid eye disease who require strabismus surgery.